arrow
P

P.L. Shaffer

Johnson & Johnson
H指数:21
被引数:2,622

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimization of Covalent 6-Cyanoquinazoline KRASG12C Inhibitors for the Treatment of Solid Tumors

共价6-氰基喹唑啉KRASG12C抑制剂的优化,用于实体瘤的治疗

2026-04-010
PRE
Author Correction: Folding-mediated secretion of pure bispecific antibodies

作者更正:折叠介导的纯双特异性抗体分泌

2025-10-280
OAAI
Folding-mediated secretion of pure bispecific antibodies

折叠介导的纯双特异性抗体分泌

2025-10-070
PRE
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo Exploration

GluN2A负性别构调节剂的分子设计、合成与表征及其在活体内的应用研究

2025-02-172
PRE
Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus Infections
2024-06-270
PRE
Identification of highly selective SIK 1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation
2023-12-267
OAAI
Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions
2022-07-2111
PRE
Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders
2020-11-1614
PREAI
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors
2016-12-2134
PREAI
Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK)
2015-01-1478
PREAI
Discovery of AM-7209, a Potent and Selective 4-Amidobenzoic Acid Inhibitor of the MDM2-p53 Interaction
2014-12-0463
PREAI
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 Interaction
2014-07-0924
OAAI